The University of Chicago Header Logo

Connection

Paul Vezina to Animals

This is a "connection" page, showing publications Paul Vezina has written about Animals.
Connection Strength

1.418
  1. Maladaptive consequences of repeated intermittent exposure to uncertainty. Prog Neuropsychopharmacol Biol Psychiatry. 2020 04 20; 99:109864.
    View in: PubMed
    Score: 0.046
  2. Exposure to conditions of uncertainty promotes the pursuit of amphetamine. Neuropsychopharmacology. 2019 01; 44(2):274-280.
    View in: PubMed
    Score: 0.041
  3. Operant responding for optogenetic excitation of LDTg inputs to the VTA requires D1 and D2 dopamine receptor activation in the NAcc. Behav Brain Res. 2017 08 30; 333:161-170.
    View in: PubMed
    Score: 0.039
  4. Sensitizing exposure to amphetamine increases AMPA receptor phosphorylation without increasing cell surface expression in the rat nucleus accumbens. Neuropharmacology. 2017 05 01; 117:328-337.
    View in: PubMed
    Score: 0.038
  5. Stimuli associated with the presence or absence of amphetamine regulate cytoskeletal signaling and behavior. Eur Neuropsychopharmacol. 2016 11; 26(11):1836-1842.
    View in: PubMed
    Score: 0.037
  6. PKC phosphorylates residues in the N-terminal of the DA transporter to regulate amphetamine-induced DA efflux. Neurosci Lett. 2016 05 27; 622:78-82.
    View in: PubMed
    Score: 0.036
  7. Drug-Paired Contextual Stimuli Increase Dendritic Spine Dynamics in Select Nucleus Accumbens Neurons. Neuropsychopharmacology. 2016 07; 41(8):2178-87.
    View in: PubMed
    Score: 0.035
  8. Inhibiting cyclin-dependent kinase 5 in the nucleus accumbens enhances the expression of amphetamine-induced locomotor conditioning. Behav Brain Res. 2014 Dec 15; 275:96-100.
    View in: PubMed
    Score: 0.032
  9. Locomotor conditioning by amphetamine requires cyclin-dependent kinase 5 signaling in the nucleus accumbens. Neuropharmacology. 2014 Oct; 85:243-52.
    View in: PubMed
    Score: 0.031
  10. Exposure to nicotine enhances its subsequent self-administration: contribution of nicotine-associated contextual stimuli. Behav Brain Res. 2014 Mar 01; 260:155-61.
    View in: PubMed
    Score: 0.030
  11. Persistent reversal of enhanced amphetamine intake by transient CaMKII inhibition. J Neurosci. 2013 Jan 23; 33(4):1411-6.
    View in: PubMed
    Score: 0.029
  12. Intermittent nicotine exposure upregulates nAChRs in VTA dopamine neurons and sensitises locomotor responding to the drug. Eur J Neurosci. 2013 Mar; 37(6):1004-11.
    View in: PubMed
    Score: 0.029
  13. Striatal ups and downs: their roles in vulnerability to addictions in humans. Neurosci Biobehav Rev. 2013 Nov; 37(9 Pt A):1999-2014.
    View in: PubMed
    Score: 0.028
  14. Enhanced dorsolateral striatal activity in drug use: the role of outcome in stimulus-response associations. Behav Brain Res. 2012 Dec 01; 235(2):136-42.
    View in: PubMed
    Score: 0.028
  15. Previous exposure to nicotine enhances the incentive motivational effects of amphetamine via nicotine-associated contextual stimuli. Neuropsychopharmacology. 2012 Sep; 37(10):2277-84.
    View in: PubMed
    Score: 0.027
  16. Unpredictable saccharin reinforcement enhances locomotor responding to amphetamine. Behav Brain Res. 2012 Jan 01; 226(1):340-4.
    View in: PubMed
    Score: 0.026
  17. Casein kinase 1 enables nucleus accumbens amphetamine-induced locomotion by regulating AMPA receptor phosphorylation. J Neurochem. 2011 Jul; 118(2):237-47.
    View in: PubMed
    Score: 0.025
  18. Previous exposure to delta9-tetrahydrocannibinol enhances locomotor responding to but not self-administration of amphetamine. J Pharmacol Exp Ther. 2011 Jun; 337(3):724-33.
    View in: PubMed
    Score: 0.025
  19. Dorsal as well as ventral striatal lesions affect levels of intravenous cocaine and morphine self-administration in rats. Neurosci Lett. 2011 Apr 08; 493(1-2):29-32.
    View in: PubMed
    Score: 0.025
  20. Transient viral-mediated overexpression of alpha-calcium/calmodulin-dependent protein kinase II in the nucleus accumbens shell leads to long-lasting functional upregulation of alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors: dopamine type-1 receptor and protein kinase A dependence. Eur J Neurosci. 2010 Apr; 31(7):1243-51.
    View in: PubMed
    Score: 0.023
  21. Transient overexpression of alpha-Ca2+/calmodulin-dependent protein kinase II in the nucleus accumbens shell enhances behavioral responding to amphetamine. J Neurosci. 2010 Jan 20; 30(3):939-49.
    View in: PubMed
    Score: 0.023
  22. The PKC inhibitor Ro31-8220 blocks acute amphetamine-induced dopamine overflow in the nucleus accumbens. Neurosci Lett. 2009 May 15; 455(2):88-92.
    View in: PubMed
    Score: 0.022
  23. Amphetamine-induced changes in dendritic morphology in rat forebrain correspond to associative drug conditioning rather than nonassociative drug sensitization. Biol Psychiatry. 2009 May 15; 65(10):835-40.
    View in: PubMed
    Score: 0.022
  24. Inhibition of CaMKII in the nucleus accumbens shell decreases enhanced amphetamine intake in sensitized rats. Neurosci Lett. 2008 Oct 24; 444(2):157-60.
    View in: PubMed
    Score: 0.021
  25. Conditioned cues and the expression of stimulant sensitization in animals and humans. Neuropharmacology. 2009; 56 Suppl 1:160-8.
    View in: PubMed
    Score: 0.021
  26. Exposure to nicotine and sensitization of nicotine-induced behaviors. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Nov 15; 31(8):1625-38.
    View in: PubMed
    Score: 0.020
  27. Sensitization, drug addiction and psychopathology in animals and humans. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Nov 15; 31(8):1553-5.
    View in: PubMed
    Score: 0.020
  28. Appetitive sensitization by amphetamine does not reduce its ability to produce conditioned taste aversion to saccharin. Behav Brain Res. 2006 Dec 15; 175(2):305-14.
    View in: PubMed
    Score: 0.018
  29. Blockade of group II metabotropic glutamate receptors in the nucleus accumbens produces hyperlocomotion in rats previously exposed to amphetamine. Neuropharmacology. 2006 Oct; 51(5):986-92.
    View in: PubMed
    Score: 0.018
  30. Locomotor activity and cocaine-seeking behavior during acquisition and reinstatement of operant self-administration behavior in rats. Behav Brain Res. 2005 May 28; 160(2):250-9.
    View in: PubMed
    Score: 0.016
  31. Activation of group II mGlu receptors blocks the enhanced drug taking induced by previous exposure to amphetamine. Eur J Neurosci. 2005 Jan; 21(1):295-300.
    View in: PubMed
    Score: 0.016
  32. Previous exposure to psychostimulants enhances the reinstatement of cocaine seeking by nucleus accumbens AMPA. Neuropsychopharmacology. 2004 Dec; 29(12):2149-59.
    View in: PubMed
    Score: 0.016
  33. Blockade of D2 dopamine receptors in the VTA induces a long-lasting enhancement of the locomotor activating effects of amphetamine. Behav Pharmacol. 2004 Sep; 15(5-6):387-95.
    View in: PubMed
    Score: 0.016
  34. Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs. Neurosci Biobehav Rev. 2004 Jan; 27(8):827-39.
    View in: PubMed
    Score: 0.015
  35. Microinjection of CART peptide 55-102 into the nucleus accumbens blocks amphetamine-induced locomotion. Neuropeptides. 2003 Dec; 37(6):369-73.
    View in: PubMed
    Score: 0.015
  36. Previous exposure to VTA amphetamine enhances cocaine self-administration under a progressive ratio schedule in an NMDA, AMPA/kainate, and metabotropic glutamate receptor-dependent manner. Neuropsychopharmacology. 2003 Apr; 28(4):629-39.
    View in: PubMed
    Score: 0.014
  37. Behavioral sensitization to quinpirole is not associated with increased nucleus accumbens dopamine overflow. Neuropharmacology. 2003 Jan; 44(1):102-10.
    View in: PubMed
    Score: 0.014
  38. Previous exposure to VTA amphetamine enhances cocaine self-administration under a progressive ratio schedule in a D1 dopamine receptor dependent manner. Neuropsychopharmacology. 2002 Dec; 27(6):970-9.
    View in: PubMed
    Score: 0.014
  39. Repeated ventral tegmental area amphetamine administration alters dopamine D1 receptor signaling in the nucleus accumbens. Synapse. 2002 Sep 01; 45(3):159-70.
    View in: PubMed
    Score: 0.014
  40. The mGlu2/3 receptor agonist LY379268 blocks the expression of locomotor sensitization by amphetamine. Pharmacol Biochem Behav. 2002 Sep; 73(2):333-7.
    View in: PubMed
    Score: 0.014
  41. Glutamate inputs from the laterodorsal tegmental nucleus to the ventral tegmental area are essential for the induction of cocaine sensitization in male mice. Psychopharmacology (Berl). 2022 Oct; 239(10):3263-3276.
    View in: PubMed
    Score: 0.014
  42. Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine. J Neurosci. 2002 Jun 01; 22(11):4654-62.
    View in: PubMed
    Score: 0.014
  43. Conditioned inhibition of amphetamine sensitization. Neurobiol Learn Mem. 2022 07; 192:107636.
    View in: PubMed
    Score: 0.014
  44. Locomotor response to novelty predicts a rat's propensity to self-administer nicotine. Psychopharmacology (Berl). 2001 Nov; 158(2):175-80.
    View in: PubMed
    Score: 0.013
  45. Sex-specific nicotine sensitization and imprinting of self-administration in rats inform GWAS findings on human addiction phenotypes. Neuropsychopharmacology. 2021 09; 46(10):1746-1756.
    View in: PubMed
    Score: 0.013
  46. Previous exposure to amphetamine enhances the subsequent locomotor response to a D1 dopamine receptor agonist when glutamate reuptake is inhibited. J Neurosci. 2001 Mar 01; 21(5):RC133.
    View in: PubMed
    Score: 0.013
  47. Induction of locomotor sensitization by amphetamine requires the activation of NMDA receptors in the rat ventral tegmental area. Psychopharmacology (Berl). 2000 Aug; 151(2-3):184-91.
    View in: PubMed
    Score: 0.012
  48. Group II, but not group I, metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion. Neuropharmacology. 2000 Jul 24; 39(10):1692-9.
    View in: PubMed
    Score: 0.012
  49. Previous exposure to amphetamine increases incentive to obtain the drug: long-lasting effects revealed by the progressive ratio schedule. Behav Brain Res. 2000 Jan; 107(1-2):9-19.
    View in: PubMed
    Score: 0.012
  50. The effect of previous exposure to amphetamine on drug-induced locomotion and self-administration of a low dose of the drug. Psychopharmacology (Berl). 1999 Nov; 147(2):125-34.
    View in: PubMed
    Score: 0.011
  51. Mesoaccumbens dopamine and the self-administration of amphetamine. Ann N Y Acad Sci. 1999 Jun 29; 877:820-2.
    View in: PubMed
    Score: 0.011
  52. Metabotropic glutamate receptors and the generation of locomotor activity: interactions with midbrain dopamine. Neurosci Biobehav Rev. 1999 Mar; 23(4):577-89.
    View in: PubMed
    Score: 0.011
  53. Blockade of glutamate reuptake in the rat nucleus accumbens increases locomotor activity. Brain Res. 1999 Feb 20; 819(1-2):165-9.
    View in: PubMed
    Score: 0.011
  54. Depletion of dopamine in the nucleus accumbens prevents the generation of locomotion by metabotropic glutamate receptor activation. Brain Res. 1998 Nov 23; 812(1-2):260-4.
    View in: PubMed
    Score: 0.011
  55. Environmental enrichment reverses increased addiction risk caused by prenatal ethanol exposure. Drug Alcohol Depend. 2018 10 01; 191:343-347.
    View in: PubMed
    Score: 0.011
  56. Prenatal ethanol exposure increases risk of psychostimulant addiction. Behav Brain Res. 2019 01 01; 356:51-61.
    View in: PubMed
    Score: 0.010
  57. D1 dopamine receptor blockade prevents the facilitation of amphetamine self-administration induced by prior exposure to the drug. Psychopharmacology (Berl). 1998 Jul; 138(2):159-66.
    View in: PubMed
    Score: 0.010
  58. Metabotropic glutamate receptors are necessary for sensitization by amphetamine. Neuroreport. 1998 Feb 16; 9(3):403-6.
    View in: PubMed
    Score: 0.010
  59. Metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion. J Pharmacol Exp Ther. 1998 Jan; 284(1):317-22.
    View in: PubMed
    Score: 0.010
  60. The metabotropic glutamate receptor antagonist (RS)-MCPG produces hyperlocomotion in amphetamine pre-exposed rats. Neuropharmacology. 1998; 37(2):189-97.
    View in: PubMed
    Score: 0.010
  61. Activation of metabotropic glutamate receptors in the rat nucleus accumbens increases locomotor activity in a dopamine-dependent manner. J Pharmacol Exp Ther. 1997 Nov; 283(2):962-8.
    View in: PubMed
    Score: 0.010
  62. Leptin in the nucleus accumbens core disrupts acute cocaine effects: Implications for GSK3ß connections. Behav Brain Res. 2018 Jan 30; 337:46-52.
    View in: PubMed
    Score: 0.010
  63. Cocaine inhibits leptin-induced increase of the cocaine- and amphetamine-regulated transcript peptide in the nucleus accumbens in rats. Neuroreport. 2017 Aug 02; 28(11):701-704.
    View in: PubMed
    Score: 0.010
  64. Effects of naltrexone on amphetamine-induced locomotion and rearing: acute and repeated injections. Psychopharmacology (Berl). 1997 Jun; 131(3):230-8.
    View in: PubMed
    Score: 0.010
  65. Predisposition to self-administer amphetamine: the contribution of response to novelty and prior exposure to the drug. Psychopharmacology (Berl). 1997 Feb; 129(3):277-84.
    View in: PubMed
    Score: 0.009
  66. In vivo microdialysis in the rat: low cost and low labor construction of a small diameter, removable, concentric-style microdialysis probe system. J Neurosci Methods. 1996 Oct; 68(2):259-67.
    View in: PubMed
    Score: 0.009
  67. D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J Neurosci. 1996 Apr 01; 16(7):2411-20.
    View in: PubMed
    Score: 0.009
  68. Excitatory synaptic function and plasticity is persistently altered in ventral tegmental area dopamine neurons after prenatal ethanol exposure. Neuropsychopharmacology. 2015 Mar; 40(4):893-905.
    View in: PubMed
    Score: 0.008
  69. Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J Pharmacol Exp Ther. 1994 Aug; 270(2):690-6.
    View in: PubMed
    Score: 0.008
  70. Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbens. Synapse. 1994 Feb; 16(2):104-12.
    View in: PubMed
    Score: 0.008
  71. Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Res. 1993 Mar 12; 605(2):332-7.
    View in: PubMed
    Score: 0.007
  72. a-1 Adrenergic receptors are localized on presynaptic elements in the nucleus accumbens and regulate mesolimbic dopamine transmission. Neuropsychopharmacology. 2012 Aug; 37(9):2161-72.
    View in: PubMed
    Score: 0.007
  73. Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injections. J Pharmacol Exp Ther. 1992 May; 261(2):484-90.
    View in: PubMed
    Score: 0.007
  74. Nicotinic excitation of serotonergic projections from dorsal raphe to the nucleus accumbens. J Neurophysiol. 2011 Aug; 106(2):801-8.
    View in: PubMed
    Score: 0.006
  75. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects. Brain Res. 1990 May 14; 516(1):99-106.
    View in: PubMed
    Score: 0.006
  76. The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res. 1989 Oct 09; 499(1):108-20.
    View in: PubMed
    Score: 0.006
  77. Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res. 1989 Aug 28; 495(2):401-6.
    View in: PubMed
    Score: 0.006
  78. Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction. Biochem Pharmacol. 2009 Oct 01; 78(7):756-65.
    View in: PubMed
    Score: 0.006
  79. Environment-specific cross-sensitization between the locomotor activating effects of morphine and amphetamine. Pharmacol Biochem Behav. 1989 Feb; 32(2):581-4.
    View in: PubMed
    Score: 0.005
  80. A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine. Psychopharmacology (Berl). 2009 May; 203(4):703-11.
    View in: PubMed
    Score: 0.005
  81. A comparison of the effects of intra-accumbens injections of amphetamine and morphine on reinstatement of heroin intravenous self-administration behavior. Brain Res. 1988 Aug 09; 457(2):287-94.
    View in: PubMed
    Score: 0.005
  82. Blockade of group II, but not group I, mGluRs in the rat nucleus accumbens inhibits the expression of conditioned hyperactivity in an amphetamine-associated environment. Behav Brain Res. 2008 Aug 05; 191(1):62-6.
    View in: PubMed
    Score: 0.005
  83. Enhanced nicotinic receptor function and drug abuse vulnerability. J Neurosci. 2007 Aug 15; 27(33):8771-8.
    View in: PubMed
    Score: 0.005
  84. Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens. Brain Res. 1987 Aug 04; 417(1):51-8.
    View in: PubMed
    Score: 0.005
  85. Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests. Pharmacology. 2007; 80(2-3):65-119.
    View in: PubMed
    Score: 0.005
  86. Absence of functional alternative complement pathway alleviates lupus cerebritis. Eur J Immunol. 2007 Jun; 37(6):1691-701.
    View in: PubMed
    Score: 0.005
  87. Conditioned locomotion and place preference elicited by tactile cues paired exclusively with morphine in an open field. Psychopharmacology (Berl). 1987; 91(3):375-80.
    View in: PubMed
    Score: 0.005
  88. Morphine conditioned place preference and locomotion: the effect of confinement during training. Psychopharmacology (Berl). 1987; 93(2):257-60.
    View in: PubMed
    Score: 0.005
  89. Hyperthermia induced by morphine administration to the VTA of the rat brain: an effect dissociable from morphine-induced reward and hyperactivity. Life Sci. 1985 Mar 18; 36(11):1095-105.
    View in: PubMed
    Score: 0.004
  90. Conditioning and place-specific sensitization of increases in activity induced by morphine in the VTA. Pharmacol Biochem Behav. 1984 Jun; 20(6):925-34.
    View in: PubMed
    Score: 0.004
  91. Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Eur J Neurosci. 1994 Mar 01; 6(3):293-8.
    View in: PubMed
    Score: 0.002
  92. Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the rat. Neurosci Lett. 1994 Feb 28; 168(1-2):111-4.
    View in: PubMed
    Score: 0.002
  93. Cortico-subcortical interactions in behavioral sensitization: differential effects of daily nicotine and morphine. Ann N Y Acad Sci. 1992 Jun 28; 654:101-16.
    View in: PubMed
    Score: 0.002
  94. Involvement of dopamine neurons in the regulation of beta-adrenergic receptor sensitivity in rat prefrontal cortex. J Neurochem. 1990 Jun; 54(6):1864-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.